BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology. 2005;128:1354-1368. [PMID: 15887117 DOI: 10.1053/j.gastro.2005.01.055] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Syn WK, Jung Y, Omenetti A, Abdelmalek M, Guy CD, Yang L, Wang J, Witek RP, Fearing CM, Pereira TA, Teaberry V, Choi SS, Conde-Vancells J, Karaca GF, Diehl AM. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 2009;137:1478-1488.e8. [PMID: 19577569 DOI: 10.1053/j.gastro.2009.06.051] [Cited by in Crossref: 179] [Cited by in F6Publishing: 173] [Article Influence: 13.8] [Reference Citation Analysis]
2 Zabron A, Edwards RJ, Khan SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech. 2013;6:281-292. [PMID: 23520144 DOI: 10.1242/dmm.010561] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
3 Wu J, Bresnick EH. Bare rudiments of notch signaling: how receptor levels are regulated. Trends in Biochemical Sciences 2007;32:477-85. [DOI: 10.1016/j.tibs.2007.09.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
4 Massi D, Tarantini F, Franchi A, Paglierani M, Di Serio C, Pellerito S, Leoncini G, Cirino G, Geppetti P, Santucci M. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol 2006;19:246-54. [PMID: 16341148 DOI: 10.1038/modpathol.3800526] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
5 Macfaul GR, Chapman RW. Sclerosing cholangitis: . Current Opinion in Gastroenterology 2006;22:288-93. [DOI: 10.1097/01.mog.0000218966.78558.67] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
6 Geisler F, Strazzabosco M. Emerging roles of Notch signaling in liver disease. Hepatology. 2015;61:382-392. [PMID: 24930574 DOI: 10.1002/hep.27268] [Cited by in Crossref: 130] [Cited by in F6Publishing: 128] [Article Influence: 16.3] [Reference Citation Analysis]
7 Kim MY, Park JH, Mo JS, Ann EJ, Han SO, Baek SH, Kim KJ, Im SY, Park JW, Choi EJ, Park HS. Downregulation by lipopolysaccharide of Notch signaling, via nitric oxide. J Cell Sci 2008;121:1466-76. [PMID: 18411251 DOI: 10.1242/jcs.019018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
8 Iwakiri Y, Kim MY. Nitric oxide in liver diseases. Trends Pharmacol Sci. 2015;36:524-536. [PMID: 26027855 DOI: 10.1016/j.tips.2015.05.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 14.7] [Reference Citation Analysis]
9 Wakabayashi N, Chartoumpekis DV, Kensler TW. Crosstalk between Nrf2 and Notch signaling. Free Radic Biol Med 2015;88:158-67. [PMID: 26003520 DOI: 10.1016/j.freeradbiomed.2015.05.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
10 Charles N, Holland EC. The perivascular niche microenvironment in brain tumor progression. Cell Cycle 2010;9:3012-21. [PMID: 20714216 DOI: 10.4161/cc.9.15.12710] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
11 Wang R, Li Y, Tsung A, Huang H, Du Q, Yang M, Deng M, Xiong S, Wang X, Zhang L, Geller DA, Cheng B, Billiar TR. iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway. Proc Natl Acad Sci USA. 2018;115:E10127-E10136. [PMID: 30297396 DOI: 10.1073/pnas.1722100115] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 14.3] [Reference Citation Analysis]
12 Andersen JB. Molecular pathogenesis of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2015;22:101-113. [PMID: 25174625 DOI: 10.1002/jhbp.155] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
13 Sicklick JK, Choi SS, Bustamante M, McCall SJ, Pérez EH, Huang J, Li YX, Rojkind M, Diehl AM. Evidence for epithelial-mesenchymal transitions in adult liver cells. Am J Physiol Gastrointest Liver Physiol. 2006;291:G575-G583. [PMID: 16710052 DOI: 10.1152/ajpgi.00102.2006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 96] [Article Influence: 5.4] [Reference Citation Analysis]
14 Cantarini MC, de la Monte SM, Pang M, Tong M, D’Errico A, Trevisani F, Wands JR. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006;44:446-457. [PMID: 16871543 DOI: 10.1002/hep.21272] [Cited by in Crossref: 95] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
15 Sassoli C, Chellini F, Pini A, Tani A, Nistri S, Nosi D, Zecchi-Orlandini S, Bani D, Formigli L. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. PLoS One 2013;8:e63896. [PMID: 23704950 DOI: 10.1371/journal.pone.0063896] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 9.6] [Reference Citation Analysis]
16 Mazur PK, Riener MO, Jochum W, Kristiansen G, Weber A, Schmid RM, Siveke JT. Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. Am J Gastroenterol. 2012;107:126-135. [PMID: 21931375 DOI: 10.1038/ajg.2011.305] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lu J, Xia Y, Chen K, Zheng Y, Wang J, Lu W, Yin Q, Wang F, Zhou Y, Guo C. Oncogenic role of the Notch pathway in primary liver cancer. Oncol Lett. 2016;12:3-10. [PMID: 27347091 DOI: 10.3892/ol.2016.4609] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
18 Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog 2015;54:1710-21. [PMID: 25491779 DOI: 10.1002/mc.22242] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
19 Miceli-Libby L, Johnson MJ, Harrington A, Hara-Kaonga B, Ng AK, Liaw L. Widespread delta-like-1 expression in normal adult mouse tissue and injured endothelium is reflected by expression of the Dll1LacZ locus. J Vasc Res. 2008;45:1-9. [PMID: 17898542 DOI: 10.1159/000109072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
20 Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK, Huang J, Choi S, Suzuki A, Diehl AM. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest. 2007;87:499-514. [PMID: 17334411 DOI: 10.1038/labinvest.3700537] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 8.2] [Reference Citation Analysis]
21 Kwon H, Song K, Han C, Zhang J, Lu L, Chen W, Wu T. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway. Am J Pathol. 2017;187:2288-2299. [PMID: 28923203 DOI: 10.1016/j.ajpath.2017.06.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
22 Aishima S, Mano Y, Tanaka Y, Kubo Y, Shirabe K, Maehara Y, Oda Y. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma. Hum Pathol. 2013;44:1031-1037. [PMID: 23260331 DOI: 10.1016/j.humpath.2012.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
23 Otte CM, Valtolina C, Vreman S, Hubers S, van Wolferen ME, Favier RP, Rothuizen J, Penning LC. Immunohistochemical evaluation of the activation of hepatic progenitor cells and their niche in feline lymphocytic cholangitis. J Feline Med Surg 2018;20:30-7. [PMID: 28349721 DOI: 10.1177/1098612X17699723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, LaHaye S, Tao G, Lucchesi PA, Lincoln J, Lilly B, Garg V. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. J Mol Cell Cardiol 2013;60:27-35. [PMID: 23583836 DOI: 10.1016/j.yjmcc.2013.04.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 11.3] [Reference Citation Analysis]
25 Lee SM, Jung CK, Ko YH, Choi JY, Lee KY, Kang CS. Expression of Notch 1 and 3 is related to inhibition of lymph node metastasis and progression in non-small cell lung carcinomas. Basic and Applied Pathology 2008;1:93-7. [DOI: 10.1111/j.1755-9294.2008.00020.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Wise C, Pilanthananond M, Perry BF, Alpini G, McNeal M, Glaser SS. Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol 2008; 14(19): 2986-2989 [PMID: 18494047 DOI: 10.3748/wjg.14.2986] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
27 Fava G. Molecular mechanisms of cholangiocarcinoma. World J Gastrointest Pathophysiol 2010; 1(1): 12-22 [PMID: 21607138 DOI: 10.4291/wjgp.v1.i1.12] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
28 von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011;46:1092-8. [DOI: 10.3109/00365521.2011.589472] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
29 Quintavalle C, Burmeister K, Piscuoglio S, Quagliata L, Karamitopoulou E, Sepe R, Fusco A, Terracciano LM, Andersen JB, Pallante P, Matter MS. High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. Mol Carcinog 2017;56:2146-57. [PMID: 28467612 DOI: 10.1002/mc.22671] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
30 López-Sánchez LM, Corrales FJ, Barcos M, Espejo I, Muñoz-Castañeda JR, Rodríguez-Ariza A. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis. Lab Invest 2010;90:116-27. [PMID: 19806079 DOI: 10.1038/labinvest.2009.104] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
31 Leite MF, Andrade VA, Nathanson MH. Signaling Pathways in Biliary Epithelial Cells. In: Dufour J, Clavien P, editors. Signaling Pathways in Liver Diseases. Berlin: Springer Berlin Heidelberg; 2010. pp. 25-39. [DOI: 10.1007/978-3-642-00150-5_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60:885-890. [PMID: 24308992 DOI: 10.1016/j.jhep.2013.11.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
33 Liu J, Ye F, Chen H, Lü W, Zhou C, Xie X. Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors. Int J Gynecol Cancer 2007;17:1293-9. [DOI: 10.1111/j.1525-1438.2007.00930.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
34 Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology. 2011;53:106-115. [PMID: 20967826 DOI: 10.1002/hep.23998] [Cited by in Crossref: 163] [Cited by in F6Publishing: 159] [Article Influence: 13.6] [Reference Citation Analysis]
35 Omenetti A, Syn WK, Jung Y, Francis H, Porrello A, Witek RP, Choi SS, Yang L, Mayo MJ, Gershwin ME. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology. 2009;50:518-527. [PMID: 19575365 DOI: 10.1002/hep.23019] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
36 Zhang W, Wang C, Yang M, Wan C. Relationship between the apoptosis and notch-1 expression in acute pancreatitis. J Huazhong Univ Sci Technolog Med Sci. 2007;27:48-50. [PMID: 17393108 DOI: 10.1007/s11596-007-0114-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Huang H, Pierstorff E, Osawa E, Ho D. Protein-Mediated Assembly of Nanodiamond Hydrogels into a Biocompatible and Biofunctional Multilayer Nanofilm. ACS Nano 2008;2:203-12. [DOI: 10.1021/nn7000867] [Cited by in Crossref: 173] [Cited by in F6Publishing: 144] [Article Influence: 12.4] [Reference Citation Analysis]
38 Lertsuwan K, Phoaubon S, Tasnawijitwong N, Lertsuwan J. Adenosine Suppresses Cholangiocarcinoma Cell Growth and Invasion in Equilibrative Nucleoside Transporters-Dependent Pathway. Int J Mol Sci 2020;21:E814. [PMID: 32012688 DOI: 10.3390/ijms21030814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies. Int J Mol Sci. 2018;19. [PMID: 30518128 DOI: 10.3390/ijms19123875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
40 Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008;48:308-21. [PMID: 18536057 DOI: 10.1002/hep.22310] [Cited by in Crossref: 470] [Cited by in F6Publishing: 444] [Article Influence: 33.6] [Reference Citation Analysis]
41 Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett. 2010;294:25-34. [PMID: 20149523 DOI: 10.1016/j.canlet.2010.01.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
42 Syn WK, Witek RP, Curbishley SM, Jung Y, Choi SS, Enrich B, Omenetti A, Agboola KM, Fearing CM, Tilg H, Adams DH, Diehl AM. Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol 2009;39:1879-92. [PMID: 19544307 DOI: 10.1002/eji.200838890] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
43 Coombes JD, Swiderska-Syn M, Dollé L, Reid D, Eksteen B, Claridge L, Briones-Orta MA, Shetty S, Oo YH, Riva A, Chokshi S, Papa S, Mi Z, Kuo PC, Williams R, Canbay A, Adams DH, Diehl AM, van Grunsven LA, Choi SS, Syn WK. Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. Gut 2015;64:1120-31. [PMID: 24902765 DOI: 10.1136/gutjnl-2013-306484] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
44 Liu J, Lu W, Ye F, Cheng X, Hong D, Hu Y, Chen H, Xie X. Hes1/Hes5 Gene Inhibits Differentiation via Down-Regulating Hash1 and Promotes Proliferation in Cervical Carcinoma Cells: . International Journal of Gynecological Cancer 2010;20:1109-16. [DOI: 10.1111/igc.0b013e3181ea74ad] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kokuryo T, Yokoyama Y, Nagino M. Recent advances in cancer stem cell research for cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2012;19:606-613. [PMID: 22907641 DOI: 10.1007/s00534-012-0542-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
46 Xie G, Karaca G, Swiderska-Syn M, Michelotti GA, Krüger L, Chen Y, Premont RT, Choi SS, Diehl AM. Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology. 2013;58:1801-1813. [PMID: 23703657 DOI: 10.1002/hep.26511] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
47 Nie AY, Mcmillian M, Brandon Parker J, Leone A, Bryant S, Yieh L, Bittner A, Nelson J, Carmen A, Wan J, Lord PG. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity: NONGENOTOXIC CARCINOGEN GENE SIGNATURE. Mol Carcinog 2006;45:914-33. [DOI: 10.1002/mc.20205] [Cited by in Crossref: 143] [Cited by in F6Publishing: 109] [Article Influence: 8.9] [Reference Citation Analysis]
48 Vaquero J, Guedj N, Clapéron A, Nguyen Ho-bouldoires TH, Paradis V, Fouassier L. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. Journal of Hepatology 2017;66:424-41. [DOI: 10.1016/j.jhep.2016.09.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 11.0] [Reference Citation Analysis]
49 Squadroni M, Tondulli L, Gatta G, Mosconi S, Beretta G, Labianca R. Cholangiocarcinoma. Crit Rev Oncol Hematol. 2017;116:11-31. [PMID: 28693792 DOI: 10.1016/j.critrevonc.2016.11.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
50 Brivio S, Cadamuro M, Fabris L, Strazzabosco M. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr. 2018;18:31-50. [PMID: 29070148 DOI: 10.3727/105221617x15088670121925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
51 Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J, Vandongen HM, Syn WK, Baroni GS, Benedetti A, Schuppan D, Diehl AM. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331-42. [PMID: 18802480 DOI: 10.1172/JCI35875] [Cited by in Crossref: 39] [Cited by in F6Publishing: 169] [Article Influence: 2.8] [Reference Citation Analysis]
52 Fava G, Lorenzini I. Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol 2012;2012:630543. [PMID: 21994887 DOI: 10.1155/2012/630543] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
53 Rizvi S, Borad MJ, Patel T, Gores GJ. Cholangiocarcinoma: molecular pathways and therapeutic opportunities. Semin Liver Dis. 2014;34:456-464. [PMID: 25369307 DOI: 10.1055/s-0034-1394144] [Cited by in Crossref: 75] [Cited by in F6Publishing: 130] [Article Influence: 9.4] [Reference Citation Analysis]
54 Bansal K, Balaji KN. Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. J Biol Chem 2011;286:5823-35. [PMID: 21156799 DOI: 10.1074/jbc.M110.192393] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
55 North TE, Goessling W, Peeters M, Li P, Ceol C, Lord AM, Weber GJ, Harris J, Cutting CC, Huang P, Dzierzak E, Zon LI. Hematopoietic stem cell development is dependent on blood flow. Cell 2009;137:736-48. [PMID: 19450519 DOI: 10.1016/j.cell.2009.04.023] [Cited by in Crossref: 308] [Cited by in F6Publishing: 288] [Article Influence: 23.7] [Reference Citation Analysis]
56 LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006;44:746-764. [PMID: 16941705 DOI: 10.1002/hep.21337] [Cited by in Crossref: 189] [Cited by in F6Publishing: 148] [Article Influence: 11.8] [Reference Citation Analysis]
57 Bansal K, Narayana Y, Patil SA, Balaji KN. M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways. J Leukoc Biol 2009;85:804-16. [PMID: 19228814 DOI: 10.1189/jlb.0908561] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
58 Labib PL, Goodchild G, Pereira SP. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer. 2019;19:185. [PMID: 30819129 DOI: 10.1186/s12885-019-5391-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 59] [Article Influence: 16.7] [Reference Citation Analysis]
59 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
60 Fava G, Marzioni M, Benedetti A, Glaser S, DeMorrow S, Francis H, Alpini G. Molecular pathology of biliary tract cancers. Cancer Lett. 2007;250:155-167. [PMID: 17069969 DOI: 10.1016/j.canlet.2006.09.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
61 Koduru S, Kumar R, Srinivasan S, Evers MB, Damodaran C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther. 2010;9:202-210. [PMID: 20053782 DOI: 10.1158/1535-7163.mct-09-0771] [Cited by in Crossref: 126] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
62 Pepin F, Bertos N, Laferrière J, Sadekova S, Souleimanova M, Zhao H, Finak G, Meterissian S, Hallett MT, Park M. Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes. Breast Cancer Res 2012;14:R120. [PMID: 22906178 DOI: 10.1186/bcr3246] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
63 Ghufran H, Azam M, Mehmood A, Butt H, Riazuddin S. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment. Exp Mol Pathol 2021;123:104715. [PMID: 34699901 DOI: 10.1016/j.yexmp.2021.104715] [Reference Citation Analysis]
64 Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K, Nakashima H, Sato N, Tanaka M, Katano M. Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 2008;134:131-44. [PMID: 18166351 DOI: 10.1053/j.gastro.2007.10.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
65 Wang X, Fu Y, Chen X, Ye J, Lü B, Ye F, Lü W, Xie X. The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study. J Cancer Res Clin Oncol 2010;136:989-96. [PMID: 20091184 DOI: 10.1007/s00432-009-0744-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
66 Kanz D, Konantz M, Alghisi E, North TE, Lengerke C. Endothelial-to-hematopoietic transition: Notch-ing vessels into blood: Endothelial-to-hematopoietic transition. Ann N Y Acad Sci 2016;1370:97-108. [DOI: 10.1111/nyas.13030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
67 Aoki S, Mizuma M, Takahashi Y, Haji Y, Okada R, Abe T, Karasawa H, Tamai K, Okada T, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Katayose Y, Unno M. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. BMC Cancer. 2016;16:854. [PMID: 27821106 DOI: 10.1186/s12885-016-2919-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
68 Chen CP, Haas-kogan D. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics. Expert Review of Molecular Diagnostics 2014;10:883-95. [DOI: 10.1586/erm.10.76] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
69 Mancinelli R, Mammola C, Sferra R, Pompili S, Vetuschi A, Pannarale L. Role of the Angiogenic Factors in Cholangiocarcinoma. Applied Sciences 2019;9:1393. [DOI: 10.3390/app9071393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
70 Rizvi S, Gores GJ. Molecular pathogenesis of cholangiocarcinoma. Dig Dis 2014;32:564-9. [PMID: 25034289 DOI: 10.1159/000360502] [Cited by in Crossref: 23] [Cited by in F6Publishing: 65] [Article Influence: 2.9] [Reference Citation Analysis]
71 Morell CM, Fiorotto R, Fabris L, Strazzabosco M. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis. Clin Res Hepatol Gastroenterol. 2013;37:447-454. [PMID: 23806629 DOI: 10.1016/j.clinre.2013.05.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
72 Andersen JB, Thorgeirsson SS. A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. Hepat Oncol 2014;1:143-57. [PMID: 24772266 DOI: 10.2217/hep.13.4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
73 El Khatib M, Bozko P, Palagani V, Malek NP, Wilkens L, Plentz RR. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo. PLoS One. 2013;8:e77433. [PMID: 24204826 DOI: 10.1371/journal.pone.0077433] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
74 Okuyama R, Tagami H, Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 2008;49:187-94. [PMID: 17624739 DOI: 10.1016/j.jdermsci.2007.05.017] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 6.8] [Reference Citation Analysis]
75 Huang H, Pierstorff E, Liu K, Ōsawa E, Ho D. Nanodiamond-Mediated Delivery of Therapeutics via Particle and Thin Film Architectures. In: Ho D, editor. Nanodiamonds. Boston: Springer US; 2010. pp. 151-74. [DOI: 10.1007/978-1-4419-0531-4_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Quillard T, Charreau B. Impact of notch signaling on inflammatory responses in cardiovascular disorders. Int J Mol Sci 2013;14:6863-88. [PMID: 23531541 DOI: 10.3390/ijms14046863] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
77 Prakobwong S, Khoontawad J, Yongvanit P, Pairojkul C, Hiraku Y, Sithithaworn P, Pinlaor P, Aggarwal BB, Pinlaor S. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int J Cancer 2011;129:88-100. [PMID: 20824699 DOI: 10.1002/ijc.25656] [Cited by in F6Publishing: 57] [Reference Citation Analysis]